Direkt zum Inhalt
Merck
  • Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents.

Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents.

Toxicology and applied pharmacology (2014-05-06)
Prakash Tiwari, Krishna P Gupta
ZUSAMMENFASSUNG

We investigated the chemopreventive effects of naturally occurring compounds like butyric acid (BA), nicotinamide (NA) and calcium glucarate (CAG) individually or in combination in 7, 12-dimethylbenz [a] anthracene (DMBA) treated mouse skin at 4 and 16 weeks, the time before and after the tumor development. DMBA application did not show any skin tumors at 4 weeks but well defined tumors appeared at 16 weeks. BA, NA or CAG prevented the tumor development significantly but the protection was highly enhanced when all these compounds were given together. In order to see the molecular changes progressing with tumors, we showed the downregulation of tumor suppressor miR-203 at 16 weeks and upregulation of histone deacetylases (HDAC), DNA methyltransferase, promoter methylation of miR-203 at 4 or 16 weeks. Regulators of micro RNA biogenesis such as DICER1 and Ago2 were also deregulated by DMBA. Proto-oncogene c-myc and BMI1 were upregulated and tumor suppressor gene p16 was downregulated by DMBA as a function of time. Effects of BA, NA or CAG were more pronounced after 16 weeks as compared to 4 weeks in preventing the tumor development and altered gene expression. Concomitant administration of BA, NA and CAG tried to prevent these alterations more effectively than that of individual compound possibly by regulating miR-203 status through epigenetic or biogenetic modulations before and after the tumor development. Study provides a rationale for chemoprevention by combination of different compounds targeting miR-203.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ethyl alcohol, Pure 200 proof, Molecular Biology
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, meets USP testing specifications
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
Ethyl alcohol, Pure 190 proof, for molecular biology
Sigma-Aldrich
Natriummetabisulfit, ReagentPlus®, ≥99%
Sigma-Aldrich
Phenylmethansulfonylfluorid, ≥98.5% (GC)
Sigma-Aldrich
Ethyl alcohol, Pure, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
Ethanol, BioUltra, Molecular Biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
Natriummetabisulfit, reagent grade, 97%
Sigma-Aldrich
Phenylmethansulfonylfluorid, ≥99.0% (T)
Sigma-Aldrich
Natriummetabisulfit, puriss., meets analytical specification of Ph. Eur., BP, NF, FCC, E223, dry, 97-100.5%
Supelco
Ethanol, wasserfrei, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ethanol, standard for GC
Sigma-Aldrich
Ethanol, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Supelco
Natriummetabisulfit, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ethanol
Supelco
Ethanol -Lösung, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
Ethanol, tested according to Ph. Eur.
USP
Dehydrated Alcohol, United States Pharmacopeia (USP) Reference Standard
Supelco
Natriummetabisulfit, analytical standard
USP
Natriummetabisulfit, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Natriummetabisulfit, tested according to Ph. Eur.